Table 5.
Multifactorial analysis - Weibull Hazard Models for main effects and 2-way interactions. (Likelihood Ratios are calculated in comparison with the main effects model in Table 5)
| Model | Type III Analysis of Effects | Log Likelihood | p (Likelihood Ratio) | |
|---|---|---|---|---|
| 1 | Factors | p | ||
| Neoadjuvant therapy (D) | 0.0062 | -44.301 | 0.1568 | |
| Resection Margin positivity (R) | 0.0324 | |||
| AJCC Stage IV vs. III or less (S) | 0.2256 | |||
| D*R | 0.1649 | |||
| 2 | Neoadjuvant therapy (D) | 0.0569 | -45.294 | 0.8933 |
| Resection Margin positivity (R) | 0.5757 | |||
| AJCC Stage IV vs. III or less (S) | 0.1435 | |||
| R*S | 0.8890 | |||
| 3 | Neoadjuvant therapy (D) | 0.6231 | -45.294 | 0.8933 |
| Resection Margin positivity (R) | 0.1646 | |||
| AJCC Stage IV vs. III or less (S) | 0.1423 | |||
| D*S | 0.8890 | |||
| 4 | Neoadjuvant therapy (D) | 0.0955 | -44.232 | 0.5434 |
| Resection Margin positivity (R) | 0.0974 | |||
| AJCC Stage IV vs. III or less (S) | 0.1856 | |||
| D*R | 0.1522 | |||
| R*S | - | |||
| S*D | - | |||